Microba Life Sciences (ASX:MAP) OCF Margin %: -77.92% (As of Dec. 2025)


What is Microba Life Sciences OCF Margin %?

Microba Life Sciences ASX:MAP +2.56% OCF Margin % is -77.92% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Microba Life Sciences ranks worse than 81.86% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Microba Life Sciences's Cash Flow from Operations for the six months ended in Dec. 2025 was A$-5.70 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2025 was A$7.32 Mil. Therefore, Microba Life Sciences's OCF Margin % for the quarter that ended in Dec. 2025 was -77.92%.

As of today, Microba Life Sciences's current OCF Yield % is -58.06%.

The historical rank and industry rank for Microba Life Sciences's OCF Margin % or its related term are showing as below:

ASX:MAP' s OCF Margin % Range Over the Past 10 Years
Min: -228.67   Med: -175.8   Max: -76.67
Current: -100.94

During the past 4 years, the highest OCF Margin % of Microba Life Sciences was -76.67%. The lowest was -228.67%. And the median was -175.80%.

ASX:MAP's OCF Margin % is ranked worse than
81.86% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755 vs ASX:MAP: -100.94

Microba Life Sciences OCF Margin % Related Terms

Microba Life Sciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences OCF Margin % Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
OCF Margin %
-222.84 -228.67 -128.76 -76.67

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only -353.65 -45.28 -33.04 -123.15 -77.92

ASX:MAP vs TMO, DHR, IDXX: OCF Margin % Comparison

For the Diagnostics & Research subindustry, Microba Life Sciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences OCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's OCF Margin % falls into.


Microba Life Sciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Microba Life Sciences's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-12.013/15.669
=-76.67 %

Microba Life Sciences's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-5.704/7.32
=-77.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -77.92% mean?
Microba Life Sciences (ASX:MAP) has a OCF Margin % of -77.92% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Microba Life Sciences and its competitors. According to the industry distribution chart, Microba Life Sciences ranks #167 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 81.9%.
Is Microba Life Sciences' OCF Margin % too high?
Microba Life Sciences' current OCF Margin % is -77.92%. Based on the distribution chart, Microba Life Sciences ranks #167 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Microba Life Sciences' OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Microba Life Sciences ranks #167 out of 204 companies for OCF Margin %. This places Microba Life Sciences in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Microba Life Sciences and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microba Life Sciences's current OCF Margin % is -77.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 84% below its estimated fair value. The current OCF Margin % is -77.92%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current OCF Margin % is -77.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.